Bardoxolone

FDA rejects Reata Pharma chronic kidney disease drug; new trial needed
MedCity News
Mon, 02/28/22 - 09:15 am
Reata Pharmaceuticals
Bardoxolone
Alport syndrome
kidney disease
FDA
Reata's bardoxolone offers promise in patients with rare kidney disorder
Endpoints
Tue, 11/12/19 - 10:22 am
Reata Pharmaceuticals
Bardoxolone
chronic kidney disease
Alport syndrome
Reata Pharmaceuticals gets orphan drug designation for bardoxolone methyl to treat ADPKD
Pharmaceutical Business Review
Thu, 06/6/19 - 12:09 pm
Reata Pharmaceuticals
ADPKD
autosomal dominant polycystic kidney disease
Bardoxolone
orphan drugs
FDA
Reata’s bardoxolone hits goals in phase 2 kidney disease trial
Fierce Biotech
Tue, 09/25/18 - 09:46 am
Reata
kidney disease
Bardoxolone
clinical trials
Reata stock surges on positive data in CKD patients
Biopharma Dive
Tue, 07/24/18 - 06:45 pm
Reata Pharmaceuticals
chronic kidney disease
Bardoxolone
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Abbott Labs Shares Slide on Kidney Study
PharmPro
Sat, 10/20/12 - 10:46 am
Abbott Laboratories
Bardoxolone
Reata Pharmaceuticals
Biogen Says Its FDA Delay Unrelated To Abbott's Failed Medicine
Forbes
Fri, 10/19/12 - 11:02 am
FDA
MS
Biogen Idec
Abbott Labs
BG-12
Bardoxolone
Abbott, Reata kidney disease drug trial stopped
Reuters
Thu, 10/18/12 - 11:42 am
Abbott
Reata
kidney disease
Bardoxolone
AbbVie
Humira
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Abbott Labs: Genes Aren't The Only Thing That Can Effectively Be Spliced
Seeking Alpha
Wed, 10/26/11 - 09:06 am
Abbott Laboratories
Bardoxolone
daclizumab
Abbott's Bardoxolone in Phase III
Yahoo/Zacks
Sat, 06/18/11 - 10:25 am
diabetes
chronic kidney disease
Bardoxolone
Abbott Laboratories
Private Biotechs Take Different Avenues to Rake in Cash
Seeking Alpha
Sun, 09/26/10 - 12:45 pm
Reata
Abbott Laboratories
Bardoxolone
chronic kidney disease
Asthmatx
Boston Scientific
CytomX
Emergent BioSolutions